Combination therapy using antibody to human siglec-9 and antibody to human nkg2a for treating cancer
US-2023085847-A1 · Mar 23, 2023 · US
This page is not indexed by search engines while we improve data quality.
Patent family 62981177
This patent family groups 3 related publications across US. Members often share priority claims or equivalent filings in different countries.
| Field | Value |
|---|---|
| Family ID | 62981177 |
| Family type | — |
| Earliest priority | Jul 10, 2017 |
| First filing country | US |
| Member publications | 3 |
| Countries | US |
| Representative publication | US2023085847A1 — Combination therapy using antibody to human siglec-9 and antibody to human nkg2a for treating cancer |
Representative publication
Best representative member for this family based on priority and filing country.
US2023085847A1 — Combination therapy using antibody to human siglec-9 and antibody to human nkg2a for treating cancer (published Mar 23, 2023)
Member publications
Related publications in this family.